Daewoong Pharmaceutical Co., Ltd (KRX:069620)
South Korea flag South Korea · Delayed Price · Currency is KRW
149,800
+500 (0.33%)
At close: Apr 8, 2026

Daewoong Pharmaceutical Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,723,6391,982,5301,454,3931,343,9321,754,4691,638,243
Market Cap Growth
24.63%36.31%8.22%-23.40%7.09%-7.75%
Enterprise Value
2,508,7902,726,2642,099,0401,735,8992,148,6962,022,062
Last Close Price
149800.00172300.00125964.64115832.21156366.58145448.14
PE Ratio
8.8010.1258.8011.0441.5466.85
Forward PE
10.2211.7614.3914.7722.7741.35
PS Ratio
1.101.261.020.981.371.42
PB Ratio
1.521.751.511.432.372.35
P/TBV Ratio
1.992.292.242.153.793.83
P/FCF Ratio
---50.3933.11150.21
P/OCF Ratio
11.5513.2928.259.8814.8440.96
PEG Ratio
0.100.191.070.780.390.24
EV/Sales Ratio
1.601.741.481.261.681.75
EV/EBITDA Ratio
8.5711.0610.8110.5315.8615.60
EV/EBIT Ratio
10.3813.9514.4514.3322.4322.79
EV/FCF Ratio
-59.27--65.0940.55185.40
Debt / Equity Ratio
0.730.730.680.470.600.64
Debt / EBITDA Ratio
3.363.363.342.683.303.44
Debt / FCF Ratio
---16.558.4340.87
Net Debt / Equity Ratio
0.580.580.550.320.410.39
Net Debt / EBITDA Ratio
2.662.662.741.842.262.10
Net Debt / FCF Ratio
-15.51-15.51-5.1411.385.7824.94
Asset Turnover
0.720.720.760.830.860.83
Inventory Turnover
2.642.642.773.063.393.54
Quick Ratio
0.660.660.550.470.680.72
Current Ratio
1.241.241.030.861.161.13
Return on Equity (ROE)
18.40%18.40%2.45%14.27%5.44%4.32%
Return on Assets (ROA)
5.63%5.63%4.84%4.54%4.03%3.99%
Return on Invested Capital (ROIC)
11.45%11.90%4.38%10.40%9.50%9.18%
Return on Capital Employed (ROCE)
11.00%11.00%10.50%11.00%8.80%9.30%
Earnings Yield
11.36%9.88%1.70%9.06%2.41%1.50%
FCF Yield
-2.46%-2.14%-7.13%1.98%3.02%0.67%
Payout Ratio
4.12%4.12%31.30%5.98%19.10%26.35%
Buyback Yield / Dilution
---0.71%-3.21%-0.59%-3.21%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.